Xeomin Launch
We are pleased to share that the first double purified neurotoxin, Xeomin, has arrived in South Africa. This will be an educational event where expertise meets pure performance.(1,2) Capacity is limited. RSVP today to book your seat. We look forward to engaging with you soon, and please feel free to reach out using the details below Kindest regards Austell Pharmaceuticals Scroll down for the program, speaker information and location map. Event Organiser: Indescribable Events Contact Details: Celeste 0832679270 |
References:
S4 XEOMIN 50 units powder for solution for injection. Each vial contains 50 units of Botulinum toxin Type A (150 kDa), free from complexing proteins. Registration no.: 53/30.5/0223. S4 XEOMIN 100 units powder for solution for injection. Each vial contains 100 units of Botulinum toxin Type A (150 kDa), free from complexing proteins. Registration no.: 53/30.5/0224. Applicant: Austell Pharmaceuticals (Pty) Ltd, 1 Sherborne Road, Parktown, Johannesburg, 2193, South Africa. Tel: 0860287835. www.austell.co.za. PMX no.: 1583_06/2023 |
Event Details
Event Date | 15-07-2023 |
Event End Date | 15-07-2023 |
Registered | 15 |
Individual Price | Free |
Location | Marriot Hotel Melrose Arch |
Provisional Program
10:00 - 11:00 |
Registration |
11:00 - 12:00 |
Purity of Xeomin - Prof. Franco Molteni MD |
12:00 - 12:30 |
Q&A |
12:30 - 13:30 |
Lunch |
13:30 - 14:30 |
Clinical Studies and Advantages of Xeomin - Prof. Molteni |
14:30 - 14:45 |
Coffee Break |
14:45 - 16:00 |
Xeomin Indications - Prof. Molteni |
16:00 - 16:30 |
Discussion / Q&A |
Speakers
Franco Molteni MD
Education/Training – Institution and location: University of Milan Medical Degree: 1981/ Certified in PM and Rehabilitation 1984
Sorry, the event is now full and we are unable to accept additional RSVP's
Member Login